通过胃肠道学家教育优化Helicobacter pylori治疗:一项前性干预研究
Miao Duan1, Qing-Zhou Kong1, Xiu-Li Zuo1
1Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China.
World journal of gastroenterology
|February 16, 2026
概括
一个单一的培训课程显著提高了胃肠道病学家的Helicobacter pylori (H. pylori) 根除率. 教育干预还加强了治疗标准化和患者审查,特别有利于缺乏经验的医生.
科学领域:
- 胃肠病学 胃肠病学
- 医学教育 医学教育
- 传染病管理 传染病管理
背景情况:
- 在诊断和治疗Helicobacter pylori (H. pylori) 感染方面的专业性对于有效的根除疗法至关重要.
- 医生在H. pylori根除成功中发挥着关键作用.
研究的目的:
- 为了评估一个单一的培训课程的有效性,专注于H. pylori根除疗法.
- 评估专业培训对胃肠道病学家H. pylori治疗结果的影响.
主要方法:
- 使用真实世界的数据进行前性,前后,非随机干预研究.
- 医生招募了25名培训前和25名培训后的患者,并比较了结果.
- 主要结局:教育干预前后的H. pylori根除率比较.
主要成果:
- 培训后的H. pylori根除率显著改善 (治疗意图:58.6%与71.6%相比;每项协议:81.2%与88.6%相比).
- 治疗标准化 (71.0% vs 89.6%) 和患者审查率 (71.4% vs 80.4%) 也显示出显著的改善.
- 没有观察到不良反应记录率的显著变化 (21.0%对21.2%).
- 经验较少,基线清除率较低的医生从培训中获得的益处更大.
结论:
- 一个单一的培训课程可以提高医生的H. pylori根除率.
- 该培训改善了治疗标准化和患者审查率.
- 教育干预对于优化H. pylori治疗方案是有价值的.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.4K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Peptic Ulcer Disease IV: Management
546
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
546
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
649
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
649
Gastritis III: Clinical Manifestations and Management
1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K
Peptic Ulcer Disease I: Introduction
900
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
900
Gastroesophageal Reflux Disease II: Clinical Features and Management
989
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
989


